|
End-of-day quote
Shenzhen S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 168.10 CNY | -7.84% |
|
-1.81% | +80.89% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 58,634 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 79.83% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 53,585 | 54,242 | 54,818 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 103.46% | 1.23% | 1.06% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 43.2x | 34.3x | 28.3x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.22x | 3.02x | 2.79x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 1.9x | 1.3x | 1.3x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.26x | 6.03x | 5.01x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 6.63x | 5.58x | 4.68x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 25.1x | 20.9x | 17.2x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 35x | 28.9x | 21x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -80.7x | 61.7x | 42.1x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -1.24% | 1.62% | 2.38% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.464 | 1.795 | 2.113 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.87% | 1.07% | 1.26% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.892 | 4.907 | 5.944 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 37.6% | 36.6% | 35.6% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,082 | 9,722 | 11,709 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,134 | 2,590 | 3,192 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,532 | 1,878 | 2,608 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,443 | 1,757 | 2,112 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -5,049 | -4,392 | -3,816 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 168.10 | 168.10 | 168.10 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 30/03/22 | 30/03/23 | 28/03/24 | 28/03/25 | 30/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 43.2x | 6.63x | 25.11x | 0.87% | 8.72B | ||
| 35.74x | 12.95x | 26.26x | 0.55% | 1,119B | ||
| 30.06x | - | - | 1.99% | 651B | ||
| 33.82x | 7.82x | 16.26x | 2.59% | 468B | ||
| 20.93x | 4.96x | 12.28x | 2.66% | 374B | ||
| 22.59x | 5.81x | 14.4x | 2.75% | 302B | ||
| 21.37x | 4.4x | 12.49x | 1.99% | 259B | ||
| 27.79x | 7.17x | 12.73x | 2.3% | 238B | ||
| 13.71x | 4.87x | 10.23x | 3.75% | 208B | ||
| -44.65x | 6.45x | 25.18x | 2.26% | 181B | ||
| Average | 20.45x | 6.78x | 17.22x | 2.17% | 380.86B | |
| Weighted average by Cap. | 25.55x | 8.50x | 18.72x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















